NOBOX is a key FOXL2 partner involved in ovarian folliculogenesis

Journal of Molecular Cell Biology

Volumn 6, Issue 2, 2014, Pages 175-177

  Bouilly, Justine ^a,b   Veitia, Reiner A ^c,d   Binart, Nadine ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c INSTITUT JACQUES MONOD   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; FORKHEAD TRANSCRIPTION FACTOR 2; HOMEODOMAIN PROTEIN; NEWBORN OOGENESIS HOMEOBOX; UNCLASSIFIED DRUG; FOXL2 PROTEIN, HUMAN; NOBOX PROTEIN, HUMAN; PROTEIN BINDING; TRANSCRIPTION FACTOR;

BINDING AFFINITY; FETUS (ANATOMY); HOMEOBOX; HUMAN; LETTER; NONHUMAN; OOCYTE; OVARY FOLLICLE CELL; OVARY FOLLICLE DEVELOPMENT; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; ANIMAL; CYTOLOGY; DEFICIENCY; FEMALE; METABOLISM; MOUSE; ORGANOGENESIS; OVARY FOLLICLE;

ANIMALS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HOMEODOMAIN PROTEINS; HUMANS; MICE; ORGANOGENESIS; OVARIAN FOLLICLE; PROTEIN BINDING; TRANSCRIPTION FACTORS;

EID: 84899684696     PISSN: 16742788     EISSN: 17594685     Source Type: Journal    
DOI: 10.1093/jmcb/mju006     Document Type: Letter

References (10)

1. Benayoun, B.A., Caburet, S., Dipietromaria, A., et al. (2008). The identification and characterization of a FOXL2 response element provides insights into the pathogenesis of mutant alleles. Hum. Mol. Genet. 17, 3118-3127.
2. Beysen, D., De, P.A., and De, B.E. (2009). FOXL2 mutations and genomic rearrangements in BPES. Hum. Mutat. 30, 158-169.
3. Bouilly, J., Bachelot, A., Broutin, I., et al. (2011). Novel NOBOX loss-of-function mutations account for 6.2% of cases in a large primary ovarian insufficiency cohort. Hum. Mutat. 32, 1108-1113.
4. Choi, Y., and Rajkovic, A. (2006). Characterization of NOBOX DNA binding specificity and its regulation of Gdf9 and Pou5f1 promoters. J. Biol. Chem. 281, 35747-35756.
5. Foucher, I., Montesinos, M.L., Volovitch, M., et al. (2003). Joint regulation of the MAP1B promoter by HNF3beta/Foxa2 and Engrailed is the result of a highly conserved mechanism for direct interaction of homeoproteins and Fox transcription factors. Development 130, 1867-1876.
6. Moumne, L., Batista, F., Benayoun, B.A., et al. (2008). The mutations and potential targets of the forkhead transcription factor FOXL2. Mol. Cell. Endocrinol. 282, 2-11.
7. Qin, Y., Choi, Y., Zhao, H., et al. (2007). NOBOX homeobox mutation causes premature ovarian failure. Am. J. Hum. Genet. 81, 576-581.
8. Rajkovic, A., Pangas, S.A., Ballow, D., et al. (2004). NOBOX deficiency disrupts early folliculogenesis and oocyte-specific gene expression. Science 305, 1157-1159.
9. Schmidt, D., Ovitt, C.E., Anlag, K., et al. (2004). The murine winged-helix transcription factor Foxl2 is required for granulosa cell differentiation and ovary maintenance. Development 131, 933-942.
10. Uda, M., Ottolenghi, C., Crisponi, L., et al. (2004). Foxl2 disruption causes mouse ovarian failure by pervasive blockage of follicle development. Hum. Mol. Genet. 13, 1171-1181.